BBVA USA’s Merck MRK Stock Holding History

BBVA USA’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.97M	Sell	26,192 -2,103	-7%	-$160K	0.12%	176
2021 Q2	$2.2M	Buy	+28,295	New	+$2.1M	0.12%	163

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

BBVA USA's MRK Position: Q3 2021 in Review

BBVA USA reduced its Merck (MRK) stake by 7.4% in Q3 2021, selling an estimated $160K and leaving 26,192 shares worth $1.97M. The position accounts for 0.12% of the portfolio, ranked #176.

BBVA USA first reported a position in MRK in Q2 2021 and has held it in 2 quarters since. The position peaked at $2.2M in Q2 2021. 2,648 funds tracked by Wall St. Rank hold MRK as of Q3 2021.

BBVA USA held 26,192 shares of Merck worth $1.97M as of Q3 2021.
BBVA USA sold 2,103 Merck shares in Q3 2021, an estimated $160K.
Merck made up 0.12% of BBVA USA's portfolio in Q3 2021, its #176 holding.
BBVA USA first reported a position in Merck in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Merck position peaked at $2.2M in Q2 2021.
2,648 funds tracked by Wall St. Rank held Merck as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.